Greg Zarbis-Papastoitsis
Keine laufenden Positionen mehr
Karriereverlauf von Greg Zarbis-Papastoitsis
Ehemalige bekannte Positionen von Greg Zarbis-Papastoitsis
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CARISMA THERAPEUTICS, INC. | Corporate Officer/Principal | 01.06.2013 | 01.06.2016 |
Ausbildung von Greg Zarbis-Papastoitsis
| State University of New York at Binghamton | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 3 |
Operativ
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |
